Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine hydrochloride with or without vismodegib in patients with recurrent or metastatic pancreatic cancer; re…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer [Phase 2]
This is a Phase 2 dose-escalation study of Erlotinib (Tarceva) in combination with Gemcitabine for metastatic pancreatic cancer. The trial c…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine with Abraxane and other investigational therapies as neoadjuvant treatment for pancreatic adenocarcinom…
-
CLINICAL_TRIALS research · 2015-02-04Clinical Trial Update: Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer [Phase 3]
An Italian multicenter Phase 3 trial compares FOLFOXIRI against Gemcitabine as adjuvant therapy after resection of pancreatic cancer; the st…
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer [Phase 2]
This is an update on a Phase 2 clinical trial evaluating cone-beam CT guided stereotactic radiation therapy for locally advanced pancreatic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Safety Study of Radiofrequency Ablation of Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 safety study evaluating radiofrequency ablation for locally advanced pancreatic cancer has completed and reported safety findings.
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating FOLFOXIRI as primary treatment for locally advanced pancreatic cancer (Stage III) has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating sorafenib with or without gemcitabine in metastatic pancreatic cancer has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study [NA]
The document reports a completed study using 18F-HX4 PET imaging to assess tumor hypoxia in gastrointestinal cancers, focusing on optimizati…
-
CLINICAL_TRIALS withdrawal · 2015-01-09Clinical Trial Update: Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer [Phase 1]
A Phase 1 trial combining dovitinib lactate, gemcitabine hydrochloride, and paclitaxel albumin-stabilized nanoparticle formulation for advan…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Chemotherapy With or Without Enoxaparin in Pancreatic Cancer [Phase 2, Phase 3]
A Phase 2/3 trial evaluating chemotherapy with versus without enoxaparin in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating the combination of lapatinib ditosylate and capecitabine in patients with metastatic pancreatic cancer; the study…
-
CLINICAL_TRIALS research · 2014-12-23Clinical Trial Update: Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy
The document discusses an ongoing study by Wakayama Medical University examining predictive risk factors for Grade C pancreatic fistula afte…
-
CLINICAL_TRIALS withdrawal · 2014-12-23Clinical Trial Update: Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer [NA]
The clinical trial NCT01927393 evaluating palliative care to improve quality of life and symptoms in stage III-IV pancreatic or ovarian canc…
-
CLINICAL_TRIALS withdrawal · 2014-12-12Clinical Trial Update: A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer [EARLY_Phase 1]
A pilot Phase 1 study of the Hedgehog pathway inhibitor LDE-225 (sonidegib) for surgically resectable pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib for stage III or stage IV pancreatic cancer was terminated; results were posted on 2014-12-10.
-
CLINICAL_TRIALS research · 2014-12-08Clinical Trial Update: Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/3 study of induction FOLFIRINOX chemotherapy followed by concurrent capecitabine and radiatio…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 study evaluating gemcitabine with fish oil in advanced pancreatic cancer has completed; no results are provided in the excerpt.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy [Phase 3]
A Phase 3 trial comparing nonstented stump-closed pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduode…
-
CLINICAL_TRIALS trial_result · 2014-12-01Clinical Trial Update: Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC) [Phase 1]
This Phase 1 trial evaluated gemcitabine with high-dose intravenous vitamin C in metastatic pancreatic cancer. The study was terminated, and…
-
CLINICAL_TRIALS trial_result · 2014-11-26Clinical Trial Update: Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer [Phase 2]
Phase 2 clinical trial update for RO4929097, a gamma secretase inhibitor, in patients with previously treated metastatic pancreatic cancer. …
-
FDA label_change · 2014-11-21FDA Approved: CREON — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for CREON (pancrelipase) from AbbVie, updating the labeling to reflect approved uses for exocrine pa…
-
CLINICAL_TRIALS research · 2014-11-19Clinical Trial Update: Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions [NA]
A clinical trial update comparing endoscopic fine-needle aspiration versus fine-needle biopsy for diagnosing solid gastrointestinal lesions;…
-
CLINICAL_TRIALS trial_result · 2014-11-10Clinical Trial Update: EUS-FNA With and Without Suction [NA]
This document reports the completion of a study comparing endoscopic ultrasound-guided fine-needle aspiration with and without suction for s…
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition [NA]
An update on a trial evaluating 4D-contrast enhanced PET-CT for tumor volume definition, with the study status listed as UNKNOWN.